Certain Restricted Stock Units of Phreesia, Inc. are subject to a Lock-Up Agreement Ending on 27-JAN-2020.
January 26, 2020
Share
Certain Restricted Stock Units of Phreesia, Inc. are subject to a Lock-Up Agreement Ending on 27-JAN-2020. These Restricted Stock Units will be under lockup for 46 days starting from 12-DEC-2019 to 27-JAN-2020.
Details:
The company's directors and executive officers and the selling stockholders in this offering have signed a lock-up agreement that prevents them from selling any of the common stock or any securities convertible into or exercisable or exchangeable for common stock for 90 days after the date of this prospectus (in the case of the selling stockholders and our directors) and 45 days after the date of this prospectus (in the case of our executive officers other than our chief executive officer) without the prior written consent of J.P. Morgan Securities LLC, subject to certain exceptions (including, in the case of directors, that they may sell shares of common stock during the period from 46 to 90 days following the date of this prospectus pursuant to a trading plan established under Rule 10b5-1 of the Exchange Act). See the section titled “Underwriting” appearing elsewhere in this prospectus for more information.
Phreesia, Inc. is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations. The Company's solutions include software-as-a-service (SaaS)-based integrated tools that manage patient access, registration and payments. In addition, its solutions include clinical assessments to screen patients for a variety of physical, behavioral and mental health conditions, helping providers to understand their patients and connect them to needed services, resulting in improved health outcomes. The Company also provides life sciences companies, health plans and other payer organizations (payers), patient advocacy, public interest and other not-for-profit organizations with a channel for direct communication with patients. The Company's solutions also include additional products and services, such as the MediFind provider directory, which helps patients find care based on providers' specific clinical expertise.